BMS-345541
BMS-345541 is a highly selective inhibitor of IKK that is used in the research of various diseases. It is known for its ability to inhibit both IKK-α and IKK-β with an IC50 of 0.3 and 4 μM, respectively.
Mechanism of Action[edit | edit source]
BMS-345541 works by inhibiting the IκB kinase (IKK) complex, which plays a crucial role in the activation of the NF-κB pathway. This pathway is involved in the regulation of various cellular processes, including inflammation, immunity, cell proliferation, and survival. By inhibiting the IKK complex, BMS-345541 can effectively suppress the activation of the NF-κB pathway, thereby potentially influencing these cellular processes.
Applications in Research[edit | edit source]
BMS-345541 has been used in various research studies to investigate the role of the NF-κB pathway in different diseases. For instance, it has been used in studies on cancer, autoimmune diseases, and inflammatory diseases. In these studies, BMS-345541 has shown potential in inhibiting the growth of cancer cells, reducing inflammation, and modulating immune responses.
Potential Therapeutic Uses[edit | edit source]
While BMS-345541 is primarily used in research, its ability to inhibit the NF-κB pathway suggests potential therapeutic uses. For example, it could potentially be used in the treatment of diseases where the NF-κB pathway is overactive, such as certain types of cancer, autoimmune diseases, and inflammatory diseases. However, more research is needed to fully understand the potential therapeutic uses of BMS-345541.
Safety and Toxicity[edit | edit source]
The safety and toxicity of BMS-345541 are not fully understood, as it is primarily used in research settings. However, like all IKK inhibitors, it has the potential to cause side effects, particularly if used in high doses or for extended periods of time. These could potentially include liver damage, gastrointestinal issues, and immune system suppression.
See Also[edit | edit source]
References[edit | edit source]
| BMS-345541 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
